A team of researchers from Kaunas University of Technology and Lithuanian University of Health Sciences proposed a non-invasive method for detection of melanoma. A patented computer-aided diagnostic system developed by Lithuanian scientists proved to be more than 90% accurate in detecting malignancy in diagnostic images of skin lesions acquired from 100 patients.
In Europe, melanoma is the fifth most common type of cancer and is the major cause of death from skin cancer. Northern Europe displays the largest age-standardised rate mortality of 3.8 per 10,000 in the region, with an incidence of 23.4.
Excision of a primary tumour remains essential in diagnosing melanoma, and the decision for the operation is generally based on the dermatoscopic evaluation of the lesion. However, the accuracy of melanoma clinical diagnosis is only at 65% and strongly relies on the experience of the physician-dermatologist carrying out the analysis.
“The novelty of our method is that it combines diagnostic information obtained from different non-invasive imaging technologies such as optical spectrophotometry and ultrasound. Based on the results of our research, we can confirm that the developed automated system can complement the non-invasive diagnostic methods currently applied in the medical practice by efficiently differentiating melanoma from a melanocytic mole”, says Professor Renaldas Raišutis, head of the team behind the research at Kaunas University of Technology.
In the study, carried out by the researchers of two Lithuanian universities, diagnostic images of skin lesions acquired from 100 different patients were evaluated. By comparing and analysing complex data on skin tumours recorded by different techniques, the researchers were able to develop a novel diagnostic system, differentiating melanoma from a benign nevus with accuracy higher than 90%.
“An efficient diagnosis of an early-stage malignant skin tumour could save critical time: more patients could be examined and more of them could be saved”, says Prof Raišutis.
According to Prof Raišutis, the novel diagnostic system is firstly aimed at medical professionals; he estimates that the price of the final product might be affordable even for smaller medical institutions. However, the team is also thinking about the solutions for individual use at home.
Following the research, the prototype of the technology was developed, and the clinical research is being carried out complying with the requirements of the protocol for the clinical research confirmed by the regional bioethics committee.
The invention was patented in Lithuania (Patent No. LT6670B) and the patent applications filed for Patent Cooperation Treaty and the United States Patent and Trademark Office.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Here’s why pancreatic cancer kills so oftenon November 12, 2020 at 9:12 am
“There are newer tests coming that could potentially detect pancreatic cancer earlier, but again, the tendency for it to spread in the early stage doesn’t ensure that real early detection will ...
- Prostate cancer: Early detection crucial but 60pc of cases in Malaysia are caught at later stageon November 11, 2020 at 11:29 pm
KUALA LUMPUR, Nov 12 ― Routine health screening is the best way to detect prostate cancer at the early stage ― giving the patient the highest survival rate. However, it seems not all men in Malaysia ...
- Pitt researchers find Affordable Care Act’s Medicaid expansions led to earlier detection of canceron November 11, 2020 at 8:01 pm
Preventive health care options ushered in by the Affordable Care Act helped doctors detect cancer in more patients earlier and may have reduced the number of late-stage cancer diagnoses around the ...
- SLNB Passes Test in High-Grade Endometrial Canceron November 11, 2020 at 8:34 am
Sentinel lymph node biopsy (SLNB) may be accurate enough to replace lymphadenectomy for detecting nodal involvement in high-grade endometrial cancer, a prospective cohort study suggested. In the ...
- 3T MRI at Belfair Integrates CorTechs Labs’ Latest Software to Support Improved Prostate Cancer Detectionon November 11, 2020 at 8:00 am
T MRI at Belfair has officially implemented CorTechs Labs’ OnQ ProstateTM to advance its radiology interpretations of prostate cancer imaging. 3T MRI at Belfair was one of the first imaging centers on ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Provectus Biopharmaceuticals Announces Acceptance of PV-10® Melanoma Abstract for Oral Presentation at Melanoma Bridge 2020on November 12, 2020 at 5:09 am
KNOXVILLE, TN, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from the Company's ongoing Phase 1b/2 study ...
- Melanoma Awareness Means Healthier Skinon November 11, 2020 at 8:07 am
The most aggressive and deadliest form of skin cancer is melanoma. Regardless of ethnicity, color, or age, melanoma will impact one in five Americans during their lifetime, which is why it is of the ...
- Peter Overton 'bruised and battered' after melanoma surgeryon November 10, 2020 at 7:51 pm
Nine News Sydney newsreader Peter Overton said "it looks like I've been glassed and stitched back together" after surgery to remove a melanoma.Overton was on the operating table on Monday to remove a ...
- Researchers propose a non-invasive, accurate method for melanoma detectionon November 9, 2020 at 9:56 pm
A team of researchers from Kaunas University of Technology and Lithuanian University of Health Sciences proposed a non-invasive method for detection of melanoma.
- OncoSec drops 11% despite positive data from TAVO + Merck's Keytruda in metastatic melanomaon November 9, 2020 at 11:20 am
(NASDAQ:ONCS) announces new positive interim data from its KEYNOTE-695 Phase 2b trial evaluating TAVO (tavokinogene telseplasmid), a DNA plasmid-based interleukin-12 (IL-12), in combination with Merck ...